PrognomiQ

aid: prognomiq
name: PrognomiQ
description: 'PrognomiQ Inc. is a Redwood City, California multi-omics diagnostics company, spun out of Seer (NASDAQ: SEER)
  in 2020, that combines proteomic, genomic, transcriptomic and metabolomic measurement with machine learning to detect cancer
  and other complex diseases earlier from a blood draw. Its first commercial product, ProVue Lung, is a proteomics-based laboratory
  developed test (LDT) intended to aid early detection of lung cancer. PrognomiQ is a clinical laboratory and life sciences
  business rather than a software vendor: as of this profile it publishes a six-page corporate marketing site, a public GitHub
  organization holding forks of open-source data-engineering tooling, and no public developer portal, API documentation or
  machine-readable API contract.'
url: https://raw.githubusercontent.com/api-evangelist/prognomiq/refs/heads/main/apis.yml
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - rate-limits
  - security
  generated: '2026-09-02'
  method: derived
image: https://prognomiq.com/wp-content/uploads/2021/01/Prognomiq_logo_2-pink-white@2x.png
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Healthcare
- Life Sciences
- Diagnostics
- Proteomics
- Multiomics
- Oncology
- Clinical Laboratory
- Early Detection
- Liquid Biopsy
tags_raw:
- Company
- Health Care
- Life Sciences
- Diagnostics
- Proteomics
- Multi-Omics
- Oncology
- Clinical Laboratory
- Early Detection
- Liquid Biopsy
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/prognomiq-domain-security.yml
- type: Website
  url: https://prognomiq.com/
- type: Blog
  url: https://prognomiq.com/news-resources/
- type: Support
  url: https://prognomiq.com/contact/
- type: PrivacyPolicy
  url: https://prognomiq.com/privacy-policy/
- type: GitHubOrganization
  url: https://github.com/prognomiq
- type: LinkedIn
  url: https://www.linkedin.com/company/prognomiq-inc/
- type: Twitter
  url: https://twitter.com/PrognomiQ_Inc
- type: Careers
  url: https://prognomiq.com/careers/
- type: LLMsTxt
  url: llms/prognomiq-llms.txt
- type: Packages
  url: packages/prognomiq-packages.yml
- type: Plans
  url: plans/prognomiq-plans-pricing.yml
- type: RateLimits
  url: rate-limits/prognomiq-rate-limits.yml
x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 6
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: PrognomiQ sells a blood-based laboratory developed test (ProVue Lung) ordered through a healthcare provider, and
    its entire public web presence is a six-page WordPress marketing site with no developer section — every contract-discovery
    path probed on prognomiq.com returned 404 and no api./developer./portal./app. subdomain resolves in DNS.
  evidence:
  - url: https://prognomiq.com/openapi.json
    status: 404
  - url: https://prognomiq.com/.well-known/agent-card.json
    status: 404
  - url: https://prognomiq.com/llms.txt
    status: 404
  - url: https://prognomiq.com/developers
    status: 404
  - url: https://github.com/prognomiq
    status: 200
  checked: '2026-08-26'